BRANFORD, Conn. -- IsoPlexis, the Superhuman Cell Company, today announced the opening of its first office in the Asia-Pacific (APAC) region headed by Jason Ou as President/General Manager, APAC Region. In this role, Mr. Ou will further advance IsoPlexis' growth in the APAC region, bolstered by a new office facility in Shanghai that will focus [...]

Multi-year, multi-million dollar collaboration will develop new tools to rapidly accelerate the development of RNA-based products, catalyzing a new era in healthcare SOUTH SAN FRANCISCO, Calif., and PARISDNA -- Script, a leader in Enzymatic DNA Synthesis (EDS) and DNA on demand, has inked a multi-million dollar, multi-year contract with Wellcome Leap to accelerate RNA products, [...]

CAMBRIDGE, UK – Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional [...]

BOSTON -- TetraScience, the R&D Data Cloud company, today announced the second phase of its European expansion plan: creating a new EMEA headquarters in Dublin. The new European center will serve as a regional home base for engineering, product support, customer success, and professional services functions, complementing a European sales office in Munich. The Dublin headquarters will facilitate support of [...]

Shimadzu Corporation is pleased to announce that the following changes of Executive Officers and Directors as of April 1st, 2022 were resolved at the Board of Directors meeting today after the deliberation and advice by the Nominating/Compensation Committee. Details of appointment and changes: Name New Title Current Title Akira Nakamoto Director, Senior Advisor Representative Director, [...]

GMP-compliant test for transduction efficiency marks a key milestone for Tapestri’s ability to power single-cell analysis in clinical trial settings for cell & gene therapies SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced today the first tech transfer of a clinical trial-ready cell and gene therapy (CGT) assay [...]

BOSTON -- NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced that it has officially opened its "Proteomics/Multi-Omics Early Access Program," to life science researchers and to CLIA certified labs developing diagnostic applications. The Company is making a limited number of systems available [...]

Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide BURLINGAME, Calif. -- Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of Katy Miles to its Board of Directors, effective as of February 1, 2022. She joins recent addition David Smoller, General Partner [...]

Automated Liquid Handling Company Earns Investment to Drive Commercial Growth BOSTON -- Avidien announced today a new financing round of $4M from BroadOak Capital Partners. The investment will help Avidien expand its product roadmap, scale commercial production, and better serve research and pharmaceutical clients. Avidien CEO and Founder Rich Cote said, "The partnership with BroadOak is exciting and ushers in [...]

Abcam to license in VHH phage library(1) from Twist, complementing in-house recombinant antibody capabilities Abcam to develop and commercialize antibodies for diagnostic and research use, with Twist retaining rights for therapeutic applications Reinforces Abcam’s commitment to consistently improve industry standards and support the sector with best-in-class reagents CAMBRIDGE, England & SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ:TWST), [...]